Protective immunity in a sample of healthy adults following vaccination with a more cost effective recombinant HBsAg vaccine

Elke, 2011, Hepatitis B and the need for a booster dose, Clin. Infect. Dis., 53, 68, 10.1093/cid/cir270 F. Noordeen, Hepatitis B virus infection: An insight into infection outcomes and recent treatment options, Virus disease, 26 (1-2) (2015) 1-8. doi: 10.1007/s13337-015-0247-y. Wang, 2018, Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study, Human Vaccines Immunotherapeut., 14, 1475, 10.1080/21645515.2018.1438090 Li, 2015, Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults, Human Vaccines Immuno Therapeutics, 11, 1108 Luo, 2012, Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period, Int. J. Infect. Dis., 16, 82, 10.1016/j.ijid.2011.10.009 Das, 2019, Hepatitis B vaccine and immunoglobulin: Key concepts, J. Clin. Translat. Hepatol., 7, 165 Michael, 2009, National Institutes of Health consensus development conference statement: Management of hepatitis B, Hepatology, 49, 4 Mohammad, 2011, Sero- protection after hepatitis B vaccination in expended programme on immunization, Br. J. Med. Practiceners, 4, 445 Abdul, 2009, Role of booster dose on antibody titre after recombinant hepatitis B vaccine, J. Med., 10, 67 Andersen, 2016, Impact of obesity and metabolic syndrome on immunity, Adv. Nutr., 7, 66, 10.3945/an.115.010207 Cook, 2008, Evidence based route of administration of vaccines, Human Vaccines, 4, 67, 10.4161/hv.4.1.4747 Lee, 2019, Comparing monovalent and combination hepatitis B vaccine outcomes in children delivered by mothers with chronic hepatitis B, J. Paediatr. Child Health, 55, 327, 10.1111/jpc.14194 Velu, 2007, Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India, World J. Gastroenterol., 13, 3084, 10.3748/wjg.v13.i22.3084 Kishino, 2018, Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults, Human Vaccines Immunotherapeut., 14, 1773, 10.1080/21645515.2018.1452578 V. Vijayakumar, R. Hari, R. Parthiban, J. Mehta, S. P. Thayagarajan, Evaluation of immunogenicity and safety of Genevac B: A new recombinant hepatitis B vaccine in comparision with Engerix B and Shanvac B in healthy adults, 22 (1) (2004) 34-38. doi: 10.1016/S0255-0857(21)02948-0. Shivananda, 2006, Comparision of two hepatitis B vaccines (Gene Vac-B and Engerix-B) in healthy infants in India, Clin. Vaccine Immunol., 13, 661, 10.1128/CVI.00087-06 Saltoǧlu, 2003, Comparison of the accelarated and classic vaccination schedules against Hepatitis B: three-week hepatitis B vaccination schedule provides immediate and protective immunity, Ann. Clin. Microbiol. Antimicrobials, 2, 1, 10.1186/1476-0711-2-10 Van Der Sande, 2006, Long-term protection against carriage of hepatitis B virus after infant vaccination, J. Infect. Dis., 193, 1528, 10.1086/503433 Young, 2001, Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination, J. Med. Virol., 64, 290, 10.1002/jmv.1049 Leroux-Roels, 2001, Prevention of hepatitis B infections: vaccination and its limitations, Acta Clin. Belg., 56, 209, 10.1179/acb.2001.032 Arun, 2012, Hepatitis B infection in microbiology laboratory workers: Prevalence, vaccination, and immunity status, Hepatitis Res. Treatment Chathuranga, 2013, Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka, Int. J. Infect. Dis., 17, 1078, 10.1016/j.ijid.2013.04.009 Noordeen, 2019, Protective immunity against hepatitis B virus infection in a group of vaccinated Sri Lankan military service men following a complete course of vaccination, Virus Dis., 30, 462, 10.1007/s13337-019-00546-1